(Q48421332)

11 February 2018

title

Therapeutic nanosystems for oncology nanomedicine (English)

1 reference

11 February 2018

1 reference

A S Gonçalves

1

1 reference

11 February 2018

A S Macedo

series ordinal

2

1 reference

11 February 2018

E B Souto

series ordinal

3

1 reference

11 February 2018

publication date

27 July 2012

1 reference

11 February 2018

Clinical and Translational Oncology

published in

1 reference

11 February 2018

volume

14

1 reference

11 February 2018

issue

12

1 reference

11 February 2018

page(s)

883-890

1 reference

11 February 2018

Cancer nanotechnology: application of nanotechnology in cancer therapy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

The footprints of cancer development: Cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

The changing role of pathology in breast cancer diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Nanoparticles for drug delivery in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Tumor Ablation and Nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Targeting nanoparticles to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Biological properties of "naked" metal nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

How to improve exposure of tumor cells to drugs: promoter drugs increase tumor uptake and penetration of effector drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

The angiogenic process as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Nanoparticle delivery for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Emerging implications of nanotechnology on cancer diagnostics and therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Modified natural nanoparticles as contrast agents for medical imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Bone repair cells for craniofacial regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Microparticles and their emerging role in cancer multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Expert opinion: Responsive polymer nanoparticles in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Active targeting schemes for nanoparticle systems in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

New therapeutic approaches in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Anti-epidermal growth factor receptor (anti-EGFR) antibody conjugated fluorescent nanoparticles probe for breast cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Targeted delivery of nanoparticles for the treatment of lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Classification of lung cancer histology by gold nanoparticle sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Rapid identification and high sensitive detection of cancer cells on the gold nanoparticle interface by combined contact angle and electrochemical measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Treatment of lung cancer via telomerase inhibition: self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2'-O-Methyl-RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nano-particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

In vitro/in vivo biorecognition of lectin-immobilized fluorescent nanospheres for human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Detection of early colorectal cancer imaged with peanut agglutinin-immobilized fluorescent nanospheres having surface poly(N-vinylacetamide) chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Anti-epithelial cell adhesion molecule monoclonal antibody conjugated fluorescent nanoparticle biosensor for sensitive detection of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Targeted human serum albumin nanoparticles for specific uptake in EGFR-Expressing colon carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Nanoliposome-mediated FL/TRAIL double-gene therapy for colon cancer: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Nanotechnological advances for the delivery of CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Biomaterial-based technologies for brain anti-cancer therapeutics and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Potential of solid lipid nanoparticles in brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

The blood-brain barrier in brain homeostasis and neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Lipid nanoparticles for brain targeting I. Formulation optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Transport of drugs across the blood-brain barrier by nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Solid lipid nanoparticles for targeted brain drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0912-1

Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles

21 January 2018

1 reference

12 December 2020

Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model

1 reference

12 December 2020

Genotoxicity evaluation of fullerene C60 nanoparticles in a comet assay using lung cells of intratracheally instilled rats

1 reference

12 December 2020

Angiogenesis inhibition for the improvement of photodynamic therapy: the revival of a promising idea

1 reference

12 December 2020

10.1007/S12094-012-0912-1

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018